Arrowhead Pharmaceuticals
ARWR
#2034
Rank
ยฃ7.02 B
Marketcap
ยฃ50.83
Share price
2.36%
Change (1 day)
213.77%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -ยฃ0.96

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -ยฃ0.93. In 2024 the company made an earnings per share (EPS) of -ยฃ3.74 a decrease over its 2023 EPS that were of -ยฃ1.43.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ0.96-74.17%
2024-ยฃ3.74161.39%
2023-ยฃ1.4317.36%
2022-ยฃ1.2219.85%
2021-ยฃ1.0261.9%
2020-ยฃ0.63-216.67%
2019ยฃ0.54-210.77%
2018-ยฃ0.4938.3%
2017-ยฃ0.35-64.93%
2016-ยฃ1.00-16.25%
2015-ยฃ1.2028%
2014-ยฃ0.93-3.85%
2013-ยฃ0.97-31.58%
2012-ยฃ1.42331.82%
2011-ยฃ0.33-51.11%
2010-ยฃ0.67-79.07%
2009-ยฃ3.21-37.68%
2008-ยฃ5.15-16.87%
2007-ยฃ6.2038.33%
2006-ยฃ4.48122.22%
2005-ยฃ2.0242.11%
2004-ยฃ1.42533.33%
2003-ยฃ0.22-99.08%
2002-ยฃ24.2625%
2001-ยฃ19.4033.33%
2000-ยฃ14.55-120%
1999ยฃ72.77-400%
1998-ยฃ24.26-81.48%
1997-ยฃ130.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Alnylam Pharmaceuticals
ALNY
ยฃ0.06724-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
ยฃ1.79-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-ยฃ2.15 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ7.80-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-ยฃ6.03 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA